| Bryan Procopio, | |
|
9314 Old Keene Mill Rd Ste A, Burke, VA 22015-4284 | |
| (703) 569-3131 | |
| Not Available |
| Full Name | Bryan Procopio |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 3 Years |
| Location | 9314 Old Keene Mill Rd Ste A, Burke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205415627 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0618003020 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Eyecare Center Pc | 0648332155 | 6 |
News Archive
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.
The Heart and Stroke Foundation (HSF) is concerned with the lack of any substantive funding in support of heart health initiatives as outlined in today's 2010 Federal Budget.
According to a preliminary study conducted by the research team, the further north you go in Britain, the more likely you are to have faecal bacteria on your hands, and men were the worse offenders.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc. (Valeant), successor in interest to Dow Pharmaceutical Sciences, Inc. (DPS), has issued an Interim Final Award in favor of Anacor, awarding Anacor $100 million in damages as well as all costs of the arbitration and reasonable attorney's fees.
› Verified 1 days ago
| Provider Name | Virginia Eyecare Center Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1700987237 PECOS PAC ID: 0648332155 Enrollment ID: O20081217000431 |
News Archive
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.
The Heart and Stroke Foundation (HSF) is concerned with the lack of any substantive funding in support of heart health initiatives as outlined in today's 2010 Federal Budget.
According to a preliminary study conducted by the research team, the further north you go in Britain, the more likely you are to have faecal bacteria on your hands, and men were the worse offenders.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc. (Valeant), successor in interest to Dow Pharmaceutical Sciences, Inc. (DPS), has issued an Interim Final Award in favor of Anacor, awarding Anacor $100 million in damages as well as all costs of the arbitration and reasonable attorney's fees.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Procopio, 9314 Old Keene Mill Rd, Ste A, Burke, VA 22015-4284 Ph: (703) 569-3131 | Bryan Procopio, 9314 Old Keene Mill Rd Ste A, Burke, VA 22015-4284 Ph: (703) 569-3131 |
News Archive
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.
The Heart and Stroke Foundation (HSF) is concerned with the lack of any substantive funding in support of heart health initiatives as outlined in today's 2010 Federal Budget.
According to a preliminary study conducted by the research team, the further north you go in Britain, the more likely you are to have faecal bacteria on your hands, and men were the worse offenders.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc. (Valeant), successor in interest to Dow Pharmaceutical Sciences, Inc. (DPS), has issued an Interim Final Award in favor of Anacor, awarding Anacor $100 million in damages as well as all costs of the arbitration and reasonable attorney's fees.
› Verified 1 days ago
Rana Iman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8990 Fern Park Dr, Suite A, Burke, VA 22015 Phone: 703-425-0600 Fax: 703-425-3982 | |
Felicia Lily Tran Chen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9580 Old Keene Mill Rd, Burke, VA 22015 Phone: 703-337-4830 | |
Thanh T Yang, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5204a Rolling Rd, Burke, VA 22015 Phone: 703-425-2000 | |
Howard Joel Kahn, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9247 Old Keene Mill Rd, Burke, VA 22015 Phone: 703-644-2020 | |
Optometric Eye Care Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5765 Burke Centre Pkwy Ste L, Burke, VA 22015 Phone: 703-250-2000 Fax: 703-978-9581 | |
Dr. Anne Meccariello, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9314 Old Keene Mill Rd, Burke, VA 22015 Phone: 703-569-3131 Fax: 703-451-9291 |